ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 129 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $17,000 | -5.6% | 11,700 | -2.5% | 0.00% | – |
Q4 2016 | $18,000 | -18.2% | 12,000 | 0.0% | 0.00% | – |
Q3 2016 | $22,000 | -18.5% | 12,000 | -27.5% | 0.00% | – |
Q2 2016 | $27,000 | -79.4% | 16,550 | -75.6% | 0.00% | – |
Q1 2016 | $131,000 | +12.0% | 67,700 | +8.0% | 0.00% | – |
Q4 2015 | $117,000 | +34.5% | 62,700 | +54.6% | 0.00% | – |
Q3 2015 | $87,000 | -65.5% | 40,550 | -27.2% | 0.00% | -100.0% |
Q2 2015 | $252,000 | -1.6% | 55,700 | -6.3% | 0.00% | 0.0% |
Q1 2015 | $256,000 | +18.0% | 59,450 | -4.9% | 0.00% | 0.0% |
Q4 2014 | $217,000 | -34.2% | 62,534 | -22.5% | 0.00% | -50.0% |
Q3 2014 | $330,000 | -28.3% | 80,684 | +2.8% | 0.00% | -33.3% |
Q2 2014 | $460,000 | -15.0% | 78,500 | -8.7% | 0.00% | 0.0% |
Q1 2014 | $541,000 | +10.2% | 85,950 | +2.4% | 0.00% | 0.0% |
Q4 2013 | $491,000 | -7.9% | 83,916 | -31.6% | 0.00% | -25.0% |
Q3 2013 | $533,000 | -39.2% | 122,700 | +7.7% | 0.00% | -33.3% |
Q2 2013 | $877,000 | – | 113,950 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |